Publication | Closed Access

Site-directed immobilization of a genetically engineered anti-methotrexate antibody via an enzymatically introduced biotin label significantly increases the binding capacity of immunoaffinity columns

Binding CapacityEngineeringBiotin LabelImmunoengineeringImmunologyBiotechnologySynthetic BiologySite-directed ImmobilizationBioconjugationImmunochemistryAntibody EngineeringAntibody ScreeningMedicineBiomolecular Engineering